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Background: Running performance is widely understood in 
terms of the Joyner model (VO2max, %VO2max at ventilatory 
threshold (VT), running economy (often measured as cost of 
running (CR) as VO2 in ml.kg‑1.km‑1). 
Objective: To test the Joyner model by evaluating a runner in 
whom one element of the Joyner model is systematically abnormal. 
Methods: The case of a two‑time Paralympian with cerebral palsy 
(CP), 2nd place in the Sydney 2000 Paralympic 1500 m (T37) is 
reported. Incremental and steady state treadmill runs as well as 
simulated competitions were completed. Incremental and steady 
state (50% PPO) cycling with two legs (2L), the non‑affected leg 
(NL), and the affected leg (AL) were also completed. 
Results: His silver medal (2000 Sydney OG) performance for 
1500 m was 269 s (4:29) (77.2% of velocity in contemporary able‑
bodied world record (WR). At the time of study, his VO2max 
was 64.2 ml.min‑1.kg‑1. His cost of running (CR) (1% grade) was 
higher, at 257 vs 228, 211 and 188 ml.kg‑1.km‑1 (for ACSM norms, 
elite Europeans, elite East Africans). During cycling, his VO2max 
with 2L, NL and AL was 3.74, 3.78 and 3.71 l.min‑1, and his gross 
efficiency (GE) was 18.4, 12.2 and 9.3%, respectively. 
Conclusions: In a former elite runner with CP, there is little 
evidence of a central oxygen transport limitation. The higher 
CR (plausibly reflected by the reduced GE of his AL) appears to 
account for much of the difference in performance compared to 
able‑bodied runners. The results provide both insight into the 
physiological limitations of runners with CP and support for the 
Joyner model of competitive running performance.
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Running performance is well described by the Joyner 
model which explains performance as a function of 
VO2max, the %VO2max at lactate/ventilatory 
threshold and running economy, often expressed at 
the cost of running (CR) or VO2 (ml.kg‑1.km‑1).[1] 
There has been general support for this model, over a generation of 
sports scientists. A novel way of further testing this model is to 
evaluate runners where one element of the model is systematically 
different. This paper reports a case study of an elite runner with 
cerebral palsy (CP). CP is “a disorder of the development of 
movement and posture, causing activity limitations attributed to 
non‑progressive disturbances in the developing fetal or infant 
brain”.[2] CP is classified from the nature of the movement disorder 
and the anatomical distribution of motor abnormalities or severity. 
Our subject had spastic hemiplegia on the right side of his body, with 
unilateral involvement or spasms of the muscles including both arm 
and leg. He began running in his youth, and competed in different 
distances (800 m, 1500 m, and 5000 m) at two Paralympic Games 
(Athens 1996, Sydney 2000). His best performance was the silver 
medal in the 1500 m (T37 class) at the Sydney 2000 Paralympic 
games. His personal bests (compared to contemporary WR’s in able‑
bodied runners were: (800 m = 132 s (2:13) vs 102.3 s 
(1:43) = 77.5%WR; 1500 m = 269 s 4:29) vs 207.7 s (3:27.7) = 77.2%WR; 
5000 m = 1060 s (17:42) vs 769.6 s (12:49.6) = 72.5%WR).
The purpose of this study is to provide insight into two aspects of 
performance in athletes with CP. First, what are the characteristics of 
running performance of a runner with CP compared to able‑bodied 
runners? Second, how do persons with CP adapt to pathological 
conditions to achieve optimal function. These authors believe that 
this is the first study to report on CR and physical adaptation in an 
elite runner with CP.
Methods
At the time of the study (2011), the subject was 31 years old. He 
had participated in the 1996 and 2000 Paralympics, and had trained 
competitively until 2004. Although not competitive at the time of 
the physiological studies, he was still running three times per week 
for 30‑40 min and cycling for transportation, mostly at intensities 
below the ventilatory threshold (VT). The study was approved by the 
university human subjects committee, according to principles of the 
Declaration of Helsinki, and the subject provided written informed 
consent.
The tests consisted of three parts: treadmill running, cycle 
ergometry and race simulations. All tests were performed at the same 
time of day (18h00‑20h00) during summer. He undertook no intense 
training for 48 hrs and no training (except cycling for transportation 
purposes) for 24 hrs before each test. Laboratory tests and races were 
separated by at least 48 hours.
The subject performed incremental treadmill running until 
exhaustion (2.68 m.s‑1 (9.64 km.h‑1) +0.22 m.s‑1 (0.8 km.h‑1) each 
minute). He also performed steady state treadmill running (5 minute 
stages with 1 min walking recovery between stages). Performed on a 
different day, the steady state runs began at 2.23 m.s‑1 (8.0 km.h‑1) and 
increased by 0.22 m.s‑1 (0.8 km.h‑1) until the velocity at blood lactate = 
4 mmol.l‑1 was exceeded. All treadmill runs were performed with the 
treadmill belt at 1% elevation to mimic wind resistance. Respiratory 
gas exchange was measured using open‑circuit spirometry, with a 
mixing chamber based metabolic system (AEI Inc, Bastrop, TX), 
and standard calibration procedures. VO2max was accepted as the 
highest continuous 30 s VO2 observed during the test. The cost of 
running (CR) was calculated from the interpolated VO2‑velocity 
relationship at a VO2 = 90% of that at VT. This was done to assure that 
the CR represented steady state conditions, and to allow comparison 
to published norms.[3] Blood lactate was measured in capillary blood 
obtained from a fingertip using dry chemistry (Lactate Plus).
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Fig. 1C. Cost of running, expressed in ml.kg-1.km-1, for the runner with CP in 
this study (light), in reference to the ACSM norms, and norms for elite 
European runners and elite East African runners (dark)[3]
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Fig. 1D. Gross efficiency during cycling at 50% of PPO in elite cyclists (dark), in 
able-bodied non-athletes (dark), with 2L by the subject with CP, and 
with the NL and AL by the subject with CP (light)
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Fig. 1A. Seasonal best 1500 m performances (closed circles), with the 
contemporary WR for reference (dashed line). Note that despite 
officially retiring from competition, the time for the 2011 time trials 
(open circle) was still in the general range of his silver medal winning 
Paralympic performance.
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Fig. 1B. Split 100 m times during 1500 m time trials (2011) (296 and 297 s), 
during the Paralympic silver medal race (2000) (269 s), and for the 
contemporary WR (208 s) for able-bodied runners. Of note is that all 
races had essentially the same pacing pattern (fast-slow-fast).
Two 1500 m time trials were performed on an outdoor 400 m track, 
with an experienced pacemaker, to allow comparison of race results 
between 2000 and 2011. The pacemaker attempted to run the pace 
that the subject believed that he could sustain. During the run, based 
on verbal communication between the subject and pacemaker (e.g. 
too slow, just right, too fast), the pace was regulated every 50‑100 m. 
During the last 400 m, the subject attempted to pass the pacemaker, 
as he would in competition. Times were recorded every 100 m.
Because running is an inherently a bilateral activity, and (as in 
this subject) CP is often a unilateral pathology the authors felt that 
it was important to assess differences between his affected leg (AL) 
and non‑affected leg (NL). Accordingly, he performed incremental 
exercise using both legs 25 W + 25 W per 60 s) and, separately, with 
both the non‑affected and affected legs (25 W + 15 W per 60 s, with 
90 s on and 30 s off). Additionally, he performed a 10 min ride at 
steady state (50% peak power output) on the same cycle ergometer 
(Lode Excalibur, Groningen, NL), both with 2L and separately with 
the AL and NL. 
Results
At the time of the study, the subject’s height and weight were 1.75 m 
and 63.3 kg respectively, which were unchanged from his competitive 
years. During his peak competitive years, he trained ~4 times weekly, 
totalling ~40 km per week, including 2‑3 interval training sessions. He 
stated that if he trained >4 days per week, he tended to become injured.
During incremental treadmill running, his VO2max = 
64.2 ml.min‑1.kg‑1, his VO2@VT = 52.8 ml.min‑1.kg‑1, his VO2@RCT 
(respiratory compensation threshold) = 60.8 ml.min‑1.kg‑1. His vMax = 
4.58 m.s‑1, vVT = 3.58 m.s‑1, vRCT = 4.25 m.s‑1, v4mmol = 3.39 m.s‑1 
and vVO2max = 4.33 m.s‑1. His gross VO2max was 4,074 ml.min‑1, 
with VT and RCT at 80% and 95% of VO2max. These percentages are 
high compared to the normal range of endurance athletes, possibly 
because the vVO2max was limited by the coordination and work 
capacity of the AL. This finding is duplicated in the cycling results. He 
remarked that during his competitive career, when he was fatigued, 
the toe of his AL tended to drop, occasionally causing him to fall.
Comparing his silver medal race in 2000 with his 2011 1500 m time 
trials shows that although he was slower (269 s (4:29) vs 297 s (4:57) 
and 296 s (4:56)) (Figure  1A), the pattern of pacing was virtually 
the same (Figure  1B). His final time in the two 2011 1500 m time 
trials represented 91.0% and 91.4% of the velocity achieved during 
his silver medal race. Although the time trials were slower than his 
Paralympic race, they were in the general range of races during his late 
competitive career, which the authors believe provides evidence that 
the data collected during 2011 is representative of his physiological 
responses during his peak competitive period in 2000.
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During cycling his peak power output (PPO) was 300 W, 105 W 
and 190 W with 2L, AL and NL, respectively. VO2max was 3.74 (2L), 
3.78 (AL) and 3.71 (NL) L.min‑1. The VO2max with 2L represented 
92% of his running VO2max. It was remarkable that during 1L cycling 
with his AL, the pedalling action was very much “whole body”, with 
a great degree of accessory muscle involvement, whereas with the NL 
the cycling action looked normal.
The higher CR of our subject is presented in Figure 1C. The CR, with 
1% grade, was 257 ml.kg‑1.km‑1 vs 228 ml.kg‑1.km‑1, 211 ml.kg‑1.km‑1 
and 188 ml.kg‑1.km‑1 vs ACSM norms, elite Europeans and elite 
East Africans, respectively.[3] The GE during cycling is presented 
in Figure 1D, which depicts the range of elite cyclists, able‑bodied 
individuals, and our subject’s values for 2L, NL and AL. GE during 2L 
steady state cycling at 50% PPO was 18.4% (150 W, VO2 = 2.42 L.min‑1, 
RER = 0.84) (at the low end of normal), during 1L cycling with NL was 
12.2% (95 W, VO2 = 2.27 L.min‑1, RER = 0.90) and during 1L cycling 
with his AL his GE was 9.3% (53 W, VO2 = 1.68 L.min‑1, RER = 0.95).
Discussion
The main finding of this case study was that an elite runner with 
CP was characterised by increased CR, which seems to define the 
mechanism of his reduced (compared to able‑bodied runners) 
performance ability more than other variables in the Joyner model 
of running. This finding was supported by a decrease in GE during 
cycling in his AL. He was able to achieve VO2max even using the 
AL, apparently by extensive use of the accessory musculature to 
overcome the strength and coordinative deficit in the AL.
Extrapolating the speed‑VO2 relationship observed in the 
laboratory his best 2011 performance would require a VO2 of 
74 ml.min‑1.kg‑1, representing 115% VO2max. Assuming that the 
CR can improve by no more than 8%[4] and that VO2max is unlikely 
to increase smore than 2% with the addition of high‑intensity 
interval training[5], the authors estimated that in Sydney at the 2000 
Paralympic Games his CR was no lower than 238 ml.kg‑1.km‑1 and 
his VO2max was no higher than 66 ml.min‑1.kg‑1. On this basis, his 
Paralympic performance of 269 s would have required a VO2 of 
79.9 ml.min‑1.kg‑1, or 121% of his estimated VO2max on race day. The 
percent of VO2max for both 2000 and 2011 performances are within 
reason for the relative intensity of elite able‑bodied runners. While 
even his estimated Sydney 2000 race day VO2max is not equivalent to 
the ~75 ml.min‑1.kg‑1 typically seen in elite middle‑distance runners 
(~85% as good), his best possible CR is high compared to elite able‑
bodied runners (~75% as good). Thus both the 2011 time trials and 
the projected values for his 2000 Paralympic performance support 
the Joyner model of running performance, and suggest that the 
primary difference between this elite runner with CP and elite able‑
bodied runners is dominantly related to an increase in the CR.[1]
His ability to adapt and have a very good performance despite the 
limitations imposed by CP appears attributable to his ability to recruit 
accessory muscles to overcome the limitations imposed by CP. This 
compensatory strategy extracts a cost in terms of reduced GE (e.g. 
increased CR), which is only possible if VO2max is reasonably high. 
A recent study from the authors’ laboratory[6] in children with CP 
demonstrated that PPO (‑25%) and Wingate PO (‑40%) were more 
depressed than VO2max (‑15%) compared to age matched controls. 
These data support the concept that limitations in mechanical 
power production (e.g. increased CR, decreased GE) contribute to 
the performance deficit in CP. They further suggest that therapeutic 
strategies with CP should include efforts to increase VO2max so that 
these patients can have the physiologic capacity to accommodate 
their neuromuscular deficit. Although not directly measured in this 
study, it is likely that the spasticity in the AL influenced the stretch‑
shortening cycle of the AL, decreasing the potential contribution 
of elastic recoil to propulsion. Further, chronic spasticity of the AL 
has the potential for reducing muscle blood flow, in much the same 
way that the extended duty cycle seen in speed skaters contributes to 
reduced muscle blood flow and VO2max.[7]
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